First Manic Attack During COVID-19 Treatment: A Case Report

On March 11, 2020, the World Health Organization declared that the infection of novel coronavirus identified in Wuhan, China, is a pandemic. Various studies have shown that SARS-CoV-2 infection can trigger psychiatric effects such as anxiety, depression, and bipolar disorder. Here, we reported a case with no significant psychiatric history who experienced first-episode mania during the COVID-19 treatment. On the third day of hospitalization, the patient's mood was elevated, she thought she can treat other patients with her special power, she was talkative and irritable. Olanzapine 20 mg was started and the patient's score on the Young Mania Rating Scale decreased on the 17th day. Psychiatric outcomes associated with covid 19 are just emerging and it seems likely to be a potential engagement for psychiatric professionals in the future. More studies are required in terms of the treatment, course, and follow-up of psychiatric sequelae in these patients

The evaluation of neutrophil-lymphocyte ratio in patients with first episode psychosis

Introduction: There is a growing consensus in the literature that inflammation may play a role in the pathophysiology of schizophrenia. The blood neutrophil-lymphocyte ratio is a simple, inexpensive and reliable marker of inflammation. The aim of this study is to assess the relationship between first episode psychosis (FEP) and neutrophil–lymphocyte ratio (NLR) and to investigate if there is a relation between NLR and severity of disease.Methods: In this retrospective study we analyzed 58 FEP patients’ medical records from January 2011 to June 2014 who had been treated at our hospital. Hematologic parameters, Brief Psychiatric Rating Scale (BPRS) scores and demographic data of the patients were obtained from the medical records of 58 FEP patients. Hematologic parameters and NLR values of 58 patients with FEP compared to values of 37 healthy control group. Correlation between NLR and BPRS scores were calculated.Results: Mean NLR was significantly higher in patients compared to control group (2.22 ± 1.25 vs. 1.63 ± 0.38, p = 0.041). Neutrophil count was not different between patients and healthy control (4.03 ± 0.70 vs. 4.20 ± 1.48, p = 0.525), but lymphocyte count was significantly lower in patients (2.56 ± 0.55 vs. 2.19 ± 0.77, p = 0.013).  In the FEP patients, NLR was not significantly correlate with severity of disease (BPRS score) (n = 58; r = 0.060, p = 0.655).Conclusion: Our findings suggest that NLR levels are increased in physically healthy antipsychotic- naive first episode psychosis patients compared to physically and mentally healthy individuals

Facial emotion recognition in psychiatrists and influences of their therapeutic identification on that ability

Objectives: Although emotional cues like facial emotion expressions seem to be important in social interaction, there is no specific training about emotional cues for psychiatrists. Here, we aimed to investigate psychiatrists' ability of facial emotion recognition and relation with their clinical identification as psychotherapy-psychopharmacology oriented or being adult and childhood-adolescent psychiatrist

Reliability and validity of the Turkish version of the acceptance and action questionnaire-substance abuse (AAQ-SA) on a clinical sample

Background: In this study, it is aimed to examine the validity and reliability of the Turkish version of the Acceptance and Action Questionnaire-Substance Abuse (AAQ-SA) which is developed for assessing psychological flexibility levels of individuals with alcohol and/or substance misuse. Methods: The research sample consisted of a total of 191 participants diagnosed with alcohol and substance use disorder. For reliability analysis, Cronbach alpha coefficient, test-retest correlation, and item-total correlation methods were used. The construct validity of the scale was carried out by exploratory factor analysis and confirmatory factor analysis methods. For assessing the criterion-related validity were used Self Concealment Scale (SCS), Addiction Profile Index (BAPI), Beck Depression Inventory (BDI), Internalized Stigma of Mental Illness Scale (ISMIS), Multidimensional Scale of Perceived Social Support (MSPSS) and Rosenberg Self-Esteem Scale (RSES).Results: Principal component analysis with varimax rotation and confirmatory factor analysis were applied to examine the factor structure of the Turkish AAQ-SA and the two-factor structure was obtained similar to the original scale. In the construct validity analysis conducted by confirmatory factor analysis method, it was determined that the regression load of one item was not at the level of significance and the item was excluded from the scale. The Cronbach alpha coefficient of the 17-item final version was 0.736 and the Cronbach alpha coefficients of the sub-scales were 0.700-0.766. The item-total score correlation coefficients ranged from 0.100 to 0.523 (p <0.01). Test-retest reliability analysis at three weeks also showed good temporal stability (r=0.83). In terms of criterion-related validity, the total score of the scale was significantly correlated with BAPI, SCS, BDI, MSPSS, ISMIS, RSES scores in the expected direction. In addition, the AAQ-SA scores were compared according to the severity of addiction which is obtained from BAPI scores and results indicated significant differenceConclusions: Our results of the study indicated that the Turkish version of the AAQ-SA can be used as a satisfactory reliable and valid scale